Literature DB >> 2266111

The secreted form of the epidermal growth factor receptor. Characterization and crystallization of the receptor-ligand complex.

N Günther1, C Betzel, W Weber.   

Abstract

A protein composed of the external domain of the epidermal growth factor (EGF) receptor is secreted by A431 human tumor cells. The soluble receptor protein was isolated in bulk quantities from cell culture supernatants. It has an intact ligand binding site, exists in a 93-kDa monomeric form, and does not undergo oligomerization upon ligand binding; thus the receptor dimerization reported for the EGF holoreceptor appears not to be a function of its external domain. The unique system of a physiological soluble receptor was utilized for a crystallization study. Crystals were obtained but only in the presence of the ligand. They contained (in equimolar amounts) receptor as well as EGF. The crystals belong to the tetragonal space group P4(3)2(1)2 or P4(1)2(1)2 with unit cell dimensions a = b = 118 A, c = 202 A. The packing density parameter was 3.55 A3/dalton, indicating the asymmetric unit to consist of one receptor-ligand complex.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266111

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Atomic force microscopy of insulin single crystals: direct visualization of molecules and crystal growth.

Authors:  C M Yip; M D Ward
Journal:  Biophys J       Date:  1996-08       Impact factor: 4.033

Review 2.  Soluble receptors for cytokines and growth factors: generation and biological function.

Authors:  S Rose-John; P C Heinrich
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

3.  Extracellular domains drive homo- but not hetero-dimerization of erbB receptors.

Authors:  K M Ferguson; P J Darling; M J Mohan; T L Macatee; M A Lemmon
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

4.  Characterization of a comparative model of the extracellular domain of the epidermal growth factor receptor.

Authors:  R N Jorissen; V C Epa; H R Treutlein; T P Garrett; C W Ward; A W Burgess
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

5.  Two EGF molecules contribute additively to stabilization of the EGFR dimer.

Authors:  M A Lemmon; Z Bu; J E Ladbury; M Zhou; D Pinchasi; I Lax; D M Engelman; J Schlessinger
Journal:  EMBO J       Date:  1997-01-15       Impact factor: 11.598

6.  Characterization of glycosylation sites of the epidermal growth factor receptor.

Authors:  Yuejun Zhen; Richard M Caprioli; James V Staros
Journal:  Biochemistry       Date:  2003-05-13       Impact factor: 3.162

7.  Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor.

Authors:  R L Woltjer; T J Lukas; J V Staros
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  An alternatively processed mRNA from the avian c-erbB gene encodes a soluble, truncated form of the receptor that can block ligand-dependent transformation.

Authors:  T W Flickinger; N J Maihle; H J Kung
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

9.  Epidermal growth factor receptor activation by diesel particles is mediated by tyrosine phosphatase inhibition.

Authors:  Tamara L Tal; Philip A Bromberg; Yumee Kim; James M Samet
Journal:  Toxicol Appl Pharmacol       Date:  2008-09-26       Impact factor: 4.219

10.  A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.

Authors:  A Yayon; Y Zimmer; G H Shen; A Avivi; Y Yarden; D Givol
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.